Regional Medical Scientific Director, Pulmonary Hypertension

We are seeking a Growth and Improvement minded Regional Medical Scientific Director | Cardiopulmonary & Pulmonary Hypertension that can help drive our Strategic Operating Priorities.
Invent | Pursue the Most Promising Internal and External Science to Address Significant Unmet Medical Needs
Execute | Prioritize Resources Behind Our Key Growth Drivers (Oncology, Vaccines, Select Specialty Areas, Animal Health) While Optimizing Our Base Business)
Adapt | Develop Our People, Culture and Business Model to Evolve with a Dynamic Landscape
Diverse Talent | We are committed to providing an inclusive and welcoming environment with supporting leadership behaviors because having a high-performing, engaged workforce is critical to our ability to deliver innovative solutions to patients and customers around the world
The Regional Medical Scientific Director | Cardiopulmonary & Pulmonary Hypertension is a credentialed (i.e., MD, PhD, PharmD or APP) therapeutic and disease area expert in Pulmonary Hypertension who engages in both scientific exchange and research support, when requested, with external scientific leaders and investigators in the medical and scientific community. Regional Medical Scientific Directors provide Scientific Leaders (SLs) balanced, factual, scientific information about non-product areas of interest to our Company and responds to scientific questions from SLs, including questions about our Company products and our Company data.
You are responsible for facilitating and developing peer-level relationships with scientific leaders in the external medical/scientific community including those investigators who have potential interest in participating in our Company research studies. This role requires you to provide support for data generation activities including our Company sponsored trials and our Company Independent Investigator Study Programs as prioritized and requested by our Research Development Division leadership.
Work Independently and as a Team member with Integrity | Precision | Accomplishment | Motivational Ambition | Respect | Inclusion
Identify, establish and manage collaborative professional relationships with national, regional and clinical practice scientific leaders (SLs) and investigators to identify and address scientific needs and to ensure access to medical and scientific information on areas of therapeutic interest and our Company's data or products in the Southeast US region
Conduct peer-level scientific discussions and maintain a reliable presence to ensure our Scientific Leaders (SLs) have a Research & Development Division/Medical Affairs contact within our Company.
Engage in proactive non-product discussions regarding scientific issues (e.g., disease states, diagnosis, epidemiology, unmet medical need, and population health, etc.) that are intended to enhance scientific discussions or inform/guide our Research & Development Division, Global Medical Affairs & Human Health strategy or our Research & Development Division's programs
Facilitate appropriate scientific exchange of information with SLs, including integration of scientific knowledge with actionable insights to inform our Research & Development Division and Human Health strategies
Communicate external stakeholder opinions, insights and feedback on new data, clinical trends and the evolving medical landscape to Medical Affairs HQ teams to enhance scientific understanding and inform internal strategies
Represent our Research & Development Division at scientific meetings and congresses and contribute to our Research & Development Division's debriefs, insight discussions and post congress reports
Support data generation activities when requested by our Research & Development Division's leadership, including our Company's Investigator Study Program (ISP), by acting as the primary liaison to investigators interested in developing and completing investigative oriented research
When requested by our Research & Develop leadership, work to identify potential investigators for consideration of participation in phase II-IV clinical development programs and provide scientific support for our Research & Development Division's sponsored trials
Provide in-depth scientific support to Health Systems Teams
Demonstrate and maintain in-depth knowledge of the assigned disease and therapeutic area(s) through educational efforts, including attendance at relevant conferences, scientific workshops, and review of key journals
Fully comply with all company policies and applicable laws, regulations, and ethical standards
Desire to contribute to an environment of belonging, engagement, equity, and empowerment by: Working to transform the environment, culture, and business landscape | Leveraging diversity and inclusion to increase competitive advantage, per global diversity and inclusion strategy | Ensuring accountability to drive an inclusive culture | Strengthening the foundational elements of diversity
Consistent adherence to field and corporate policies and Global Medical Scientific Affairs (GMSA) strategy, including field standard operating procedures (SOPs), Good Clinical Practice (GCP) guidelines, and administrative/operational responsibilities
D. or APP that is relevant to the Pulmonary Hypertension area are requirements of the position

Three years in the biotech/pharmaceutical or healthcare environment
Three years clinical and/or research (beyond that obtained in the terminal degree program) in the Cardiovascular & Pulmonary therapeutic areas and demonstrated scientific excellence in the therapeutic areas or five years of Medical Scientific Liaison (MSL) in a relevant therapeutic areas and demonstration of scientific excellence in the therapeutic areas
Principled interpersonal, communication, networking, and presentation skills
Network and partner with important external customers, including scientific leaders, investigators, clinical practice leaders and academic affiliated institutions, including treatment guideline members
Recognition for scientific excellence in the Cardiovascular & Pulmonary therapeutic areas as demonstrated by sustained contributions to the therapeutic areas via strong clinical, academic and/or translational/basic science research experience in the disease area(s) of interest
experience in late stage clinical research as an investigator or key study personnel conducting outcomes research, company sponsored trials, or investigator-initiated trials)
Five years of prior pharmaceutical industry experience (Medical Scientific Liaison or other clinical, medical or research related position) in the relevant TA/disease state
Prior working experience within the given geography and established relationships with relevant therapeutic area stakeholders
Strong working knowledge of Microsoft Office Suite (Word, PowerPoint, Excel)
Consolidate and understand complex data sets, plan and/or execute data analyses, summarize, or synthesize data and objectively interpret results
Knowledge of national and society treatment guidelines, clinical research processes, FDA regulations, and OIG, HIPAA and other ethical guidelines, laws, and regulations relevant to the pharmaceutical industry and its external stakeholder environment
Travel
~ Up to 50% travel, including overnight

Hybrid Work Model
Effective September 5, 2023, employees in office-based positions in the U.S. will be working a Hybrid work consisting of three total days on-site per week, Monday - Thursday, although the specific days may vary by site or organization, with Friday designated as a remote-working day, unless business critical tasks require an on-site presence. This Hybrid work model does not apply to, and daily in-person attendance is required for, field-based positions; facility-based, manufacturing-based, or research-based positions where the work to be performed is located at a Company site; positions covered by a collective-bargaining agreement (unless the agreement provides for hybrid work); or any other position for which the Company has determined the job requirements cannot be reasonably met working remotely. Please note, this Hybrid work model guidance also does not apply to roles that have been designated as remote.